Pitrè D, Maffei-Facino R
Farmaco Sci. 1977 Jun;32(6):453-60.
Together with the metabolites arised from the reductive cleavage of the azo linkage, two hydroxylated metabolites of phenazopyridine (2,6-diamino-3-[(4-hydroxyphenyl)azo]pyridine and and 2,6-diamino-3-[(2-hydroxyphenyl)azo]pyridine) were identified in rat urine, after the administration of 50 mg/kg of the drug. The structures of these metabolites were elucidated, after TLC separation, by means of I.R., N.M.R. and mass spectrometry. The presence of two hydroxylated metabolites of the intact drug support evidence that phenazopyridine is also subjected in vivo to oxidative metabolism.
在给予大鼠50mg/kg的该药物后,在大鼠尿液中鉴定出了与偶氮键还原裂解产生的代谢物一起的两种非那吡啶的羟基化代谢物(2,6-二氨基-3-[(4-羟基苯基)偶氮]吡啶和2,6-二氨基-3-[(2-羟基苯基)偶氮]吡啶)。在薄层色谱分离后,通过红外光谱、核磁共振和质谱法阐明了这些代谢物的结构。完整药物的两种羟基化代谢物的存在证明了非那吡啶在体内也会经历氧化代谢。